Today's Brokerage Rating: Geron Corporation (GERN), AmerisourceBergen Corporation

Share

AmerisourceBergen Corporation (NYSE:ABC) ended its day at $75.40 with the rising stream of 0.53% and its total traded volume was 2.89 million shares more than the average volume. The consensus mean EPS for the current quarter is at $-0.04 derived from a total of 3 estimates from the analysts who have weighed in on projected earnings. The biopharmaceutical company reported ($0.02) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.06) by $0.04.

Recent insider trends for Geron Corporation (NASDAQ:GERN) have caught the attention of investors.

In the most updated research from a number of analysts on Wall Street, the company gets 1 Buys and 0 Sell among 4 analysts. Stifel Nicolaus now has a $2.50 price objective on the biopharmaceutical company's stock.

Geron Corporation (GERN) has risen 4.28% since then. Finally, Zacks Investment Research raised shares of Geron Corp. from a "hold" rating to a "strong-buy" rating and set a $3.00 price target on the stock in a research note on Friday, August 5th.

Taking a broader look at the analyst consensus, according to 2 analysts Geron Corporation (NASDAQ:GERN)'s price will reach at $3.75 during 52 weeks. This works out to a net increase in ownership of 2.06 million shares, and suggests that institutions are feeling bullish about the stock. For the full year, analysts expect earnings to decline -10.53% yoy to -$0.17. Analyzing the last five market sessions, the stock was able to report -5.34% losses, thus going down by -17.79%, compared with its 200-day moving average of $2.44. BTIG Research reaffirmed a "neutral" rating on shares of Geron Corp.in a research note on Tuesday, September 20th. Needham & Company LLC restated a "hold" rating on shares of Geron Corporation in a research report on Friday, November 3rd. Revenue during the quarter was $507.84 million, representing -4% growth from $529.5 million in year-ago quarter. If you are reading this article on another publication, it was illegally copied and reposted in violation of global copyright and trademark legislation.

COPYRIGHT VIOLATION NOTICE: "Favorable Media Coverage Somewhat Unlikely to Affect Geron Corporation (GERN) Stock Price" was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2017/11/13/geron-corporations-gern-hold-rating-reaffirmed-at-stifel-nicolaus.html. Russell Investments Group Ltd. bought a new position in shares of Geron Corporation in the second quarter worth about $114,000. Tudor Investment Corp ET AL boosted its holdings in shares of Geron Corporation by 12.1% in the 1st quarter. IHT Wealth Management LLC bought a new position in shares of Geron Corporation in the second quarter worth about $122,000. Vanguard Group Inc. now owns 6,296,230 shares of the biopharmaceutical company's stock valued at $16,874,000 after buying an additional 465,626 shares in the last quarter. Parametric Portfolio Associates LLC raised its stake in shares of Geron Corporation by 59.4% in the second quarter. Tudor Investment Corp ET AL now owns 52,369 shares of the biopharmaceutical company's stock worth $119,000 after acquiring an additional 5,669 shares in the last quarter.

Currently Geron Corporation (NASDAQ:GERN)'s shares owned by insiders are 0.1%, whereas shares owned by institutional owners are 39.2%. Using its nucleic acid chemistry, Geron designed Imetelstat to be an oligonucleotide that binds with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity.

Share

Advertisement

Related Posts

The Short Interest in United States Steel Corp. (X) Drops By 8.1%
Jennison Associates LLC acquired a new stake in United States Steel Corporation in the 2nd quarter worth about $20,786,000. Analysts believe that the company has the potential to earn average revenue of $1.44 Billion for the current quarter.

Meet Lebanese-origin Alex Azar, Trump's pick for health secretary
Azar served as the president of the American division of pharmaceutical giant Eli Lilly from 2012 until January of this year. Bush's first term, which was his first healthcare-focused professional role.

Neither Hold nor sell rating on Healthcare Stock: OncoSec Medical Incorporated (ONCS)
Staying on top of longer-term price action may help provide investors with a wider range of reference when doing stock analysis. International Paper Company , a US based Company, belongs to Consumer Goods sector and Packaging & Containers industry.

Intuit Inc. (INTU) Now Covered by Analysts at UBS AG
Godshalk Welsh Capital Mngmt invested 1.81% of its portfolio in Intuit Inc. (NASDAQ:INTU) rating on Thursday, September 21. The United Kingdom-based Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust has invested 6.41% in the stock.

McLaren Ultimate Series Hypercar Teased Before December 10 Reveal
It will be unveiled in an online exhibition on 10 December with its public debut penned in for the Geneva Motor Show next March. Last month, McLaren teased the triple exhaust outlets of the vehicle as the first teaser of the upcoming Ultimate Series model.

Barrick Gold Corp (ABX) Investment Up in Latest Report from Alliancebernstein LP
Majedie Asset Management Ltd increased its position in shares of Barrick Gold Corporation by 7.8% in the second quarter. Franklin Resources Inc. increased its position in shares of Barrick Gold Corporation by 41.7% in the second quarter.

Buffon quits as Italy suffer World Cup 'apocalypse'
It was 1958 and the World Cup was actually held in Sweden across 22 days in June with the hosts finishing runners-up to Brazil. Italian fans were struggling to come to terms with the prospect of a World Cup without their national team.

Fatal Crash on I-5 in Del Mar Slows Morning Commute
About half a mile south of that collision, a pickup truck crashed into several vehicles about 4:45 a.m. A 27-year-old La Mesa man driving a Toyota struck the center divide about 2:30 a.m.

Stock Stepping Up to a Recent High: Enphase Energy, Inc. (NASDAQ:ENPH)
Its minimum price target estimates has been figured out at $1.53 while the maximum price target forecast is established at $2.5. ValuEngine raised shares of Enphase Energy from a strong sell rating to a sell rating in a report on Wednesday, September 27th.

International Monetary Fund raises S.Korea 2017 growth outlook, cites robust exports
The worldwide body recommended South Korea to maintain accommodative monetary policy and expansionary fiscal policy. The IMF raised its 2017 GDP estimate to 3.2 percent from 3 percent projected in September.

© 2015 ExpressNewsline. All Rights reserved.